Linsey Reavie, Ph.D. - Publications

Affiliations: 
2012 Basic Medical Science New York University, New York, NY, United States 
Area:
Cell Biology, Human Development, General Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Koren S, Reavie L, Couto JP, De Silva D, Stadler MB, Roloff T, Britschgi A, Eichlisberger T, Kohler H, Aina O, Cardiff RD, Bentires-Alj M. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 525: 114-8. PMID 26266975 DOI: 10.1038/nature14669  0.36
2015 Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, Coffre M, Cordon-Cardo C, Aifantis I, Ibrahim S, Liu C, Koralov SB, Hernando E. Limited miR-17-92 overexpression drives hematologic malignancies. Leukemia Research. 39: 335-41. PMID 25597017 DOI: 10.1016/j.leukres.2014.12.002  0.48
2013 King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P, Aranda-Orgilles B, Perez-Garcia A, Shi J, Vakoc C, Sandy P, Shen SS, Ferrando A, Aifantis I. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell. 153: 1552-66. PMID 23791182 DOI: 10.1016/j.cell.2013.05.041  0.48
2013 Reavie L, Buckley SM, Loizou E, Takeishi S, Aranda-Orgilles B, Ndiaye-Lobry D, Abdel-Wahab O, Ibrahim S, Nakayama KI, Aifantis I. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell. 23: 362-75. PMID 23518350 DOI: 10.1016/j.ccr.2013.01.025  0.36
2012 Moran-Crusio K, Reavie LB, Aifantis I. Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system. Trends in Immunology. 33: 357-63. PMID 22349458 DOI: 10.1016/j.it.2012.01.009  0.48
2011 Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, Perna F, Pandey S, Madzo J, Song C, Dai Q, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 20: 11-24. PMID 21723200 DOI: 10.1016/j.ccr.2011.06.001  0.36
2010 Crusio KM, King B, Reavie LB, Aifantis I. The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation. Oncogene. 29: 4865-73. PMID 20543859 DOI: 10.1038/onc.2010.222  0.48
2010 Reavie L, Della Gatta G, Crusio K, Aranda-Orgilles B, Buckley SM, Thompson B, Lee E, Gao J, Bredemeyer AL, Helmink BA, Zavadil J, Sleckman BP, Palomero T, Ferrando A, Aifantis I. Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex. Nature Immunology. 11: 207-15. PMID 20081848 DOI: 10.1038/ni.1839  0.36
2010 Nakada M, Anderson EM, Demuth T, Nakada S, Reavie LB, Drake KL, Hoelzinger DB, Berens ME. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. International Journal of Cancer. Journal International Du Cancer. 126: 1155-65. PMID 19728339 DOI: 10.1002/ijc.24849  0.36
2009 Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature. 459: 1000-4. PMID 19536265 DOI: 10.1038/nature08020  0.36
2008 Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, Holz D, Joy A, Lin R, Pan KH, Lih CJ, et al. Glioma cells on the run - The migratory transcriptome of 10 human glioma cell lines Bmc Genomics. 9. PMID 18230158 DOI: 10.1186/1471-2164-9-54  0.36
2007 Demuth T, Reavie LB, Rennert JL, Nakada M, Nakada S, Hoelzinger DB, Beaudry CE, Henrichs AN, Anderson EM, Berens ME. MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Molecular Cancer Therapeutics. 6: 1212-22. PMID 17406030 DOI: 10.1158/1535-7163.MCT-06-0711  0.36
2007 Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2038-45. PMID 17404084 DOI: 10.1158/1078-0432.CCR-06-2149  0.36
Show low-probability matches.